ConductScience.org, home

Paper24847

Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).

Claflin AJ and 8 others. Proc Natl Acad Sci U S A, 1978. Cited by 50 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). Papers, record 24847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24847

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2019-05-01
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Claflin AJA J
2Vesely DLD L
3Hudson JLJ L
4Bagwell CBC B
5Lehotay DCD C
6Lo TMT M
7Fletcher MAM A
8Block NLN L
9Levey GSG S

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Guanylate CyclaseMajor topic
Plant ExtractsMajor topic
Prostatic NeoplasmsMajor topic
Animals
Cell Cycle
Concanavalin A
Cyclic GMP
In Vitro Techniques
Male
Neoplasms, Experimental
Thymidine

Source PubMed

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,888Activation of guanylate cyclase by streptozotocin and 1-methyl-1-nitrosourea.Cancer Res1977https://conductscience.org/library/papers/11888PubMed
212,374Guanylate cyclase activity in fetal, neonatal and adult rat heart.J Mol Cell Cardiol1976https://conductscience.org/library/papers/12374PubMed
313,797Hydrazine activation of guanylate cyclase: potential application to tobacco carcinogenesis.Biochem Biophys Res Commun1977https://conductscience.org/library/papers/13797PubMed
414,073,009PROSTATE CANCER IN THE RAT.Natl Cancer Inst Monogr1963https://conductscience.org/library/papers/14073009PubMed
514,859Decreased rat hepatic guanylate cyclase activity in streptozotocin-induced diabetes mellitus.Diabetes1977https://conductscience.org/library/papers/14859PubMed
7173,021Cyclic guanosine monophosphate and cellular growth.Science1975https://conductscience.org/library/papers/173021PubMed
8175,089The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.J Clin Invest1976https://conductscience.org/library/papers/175089PubMed
9176,557A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues.Life Sci1976https://conductscience.org/library/papers/176557PubMed
1017,868Enhancement of human guanylate cyclase activity by chemical carcinogens.Proc Soc Exp Biol Med1977https://conductscience.org/library/papers/17868PubMed
1120,099Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata).Biochem Biophys Res Commun1977https://conductscience.org/library/papers/20099PubMed
12239,404Increased particulate and decreased soluble guanylate cyclase activity in regenerating liver, fetal liver, and hepatoma.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/239404PubMed
13241,939Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase.Nature1975https://conductscience.org/library/papers/241939PubMed
144,153,265Activation of guanyl cyclase and intracellular cyclic GMP by fibroblast growth factor.Nature1974https://conductscience.org/library/papers/4153265PubMed
154,334,491Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.J Biol Chem1972https://conductscience.org/library/papers/4334491PubMed
164,342,973Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes.Proc Natl Acad Sci U S A1972https://conductscience.org/library/papers/4342973PubMed
174,352,647Pleiotypic control by cyclic AMP: interaction with cyclic GMP and possible role of microtubules.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4352647PubMed
184,357,771Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells.Nature1973https://conductscience.org/library/papers/4357771PubMed
194,362,085Possible involvement of cyclic GMP in growth control of cultured mouse cells.Nature1974https://conductscience.org/library/papers/4362085PubMed
204,372,536Cyclic GMP stimulates lymphocyte nucleic acid synthesis.Nature1974https://conductscience.org/library/papers/4372536PubMed
214,645,593Immune responses in vitro. V. Role of mercaptoethanol in the mixed-leukocyte reaction.Cell Immunol1972https://conductscience.org/library/papers/4645593PubMed

See all 24 references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
32,726,914Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy.Cancers (Basel)2020https://conductscience.org/library/papers/32726914PubMed
29,182,587Recent Advances in Momordica charantia: Functional Components and Biological Activities.Int J Mol Sci2017https://conductscience.org/library/papers/29182587PubMed
27,452,666Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.Semin Cancer Biol2016https://conductscience.org/library/papers/27452666PubMed
25,672,620Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells.Int J Oncol2015https://conductscience.org/library/papers/25672620PubMed
24,297,707Effect of α, β momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.Mol Cell Biochem2014https://conductscience.org/library/papers/24297707PubMed
22,654,956Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells.Evid Based Complement Alternat Med2012https://conductscience.org/library/papers/22654956PubMed
6,114,928Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.Infect Immun1981https://conductscience.org/library/papers/6114928PubMed
2,503,472Epidemiologic survey on lung cancer with respect to cigarette smoking and plant diet.Jpn J Cancer Res1989https://conductscience.org/library/papers/2503472PubMed
40,226Testosterone and its precursors and metabolites enhance guanylate cyclase activity.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/40226PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24847

GET https://conductscience.org/api/papers/v1/24847/references?page=2